AI Terminal
Ion Beam Applications, SA
Major Shareholding Notification • Apr 28, 2025
3960_mrq_2025-04-28_eeca1e14-ee93-430e-adeb-a74c73e8fbb5.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
IBA – TRANSPARENCY NOTIFICATION
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, April 28th, 2024 06:00 PM
Summary of the notification
IBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on April 8th, 2025.
In its notification, FMR LLC indicated that following an acquisition or disposal of securities or voting rights, 1% threshold crossed downards by Fidelity Management & Research Company LLC, a controlled undertaking of FMR LLC on 3/04/2025.
Content of the notification
- Reason for the notification: Acquisition or disposal of voting securities or voting rights, and downward crossing of the lowest threshold
- Notification by: A parent company or controlling person
- Persons subject to the notification requirement:
| Name | Address (for legal entities) | ||
|---|---|---|---|
| FMR LLC | The Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801. |
- Date on which the threshold is crossed: 3/04/2025
- Threshold crossed (in %) : 1%
- Denominator : 40.514.366
- Notified details: (extract of the received notification form)
Press release | 28/04/2025
1
| A) Voting rights | Previous notification | After the transaction | |||||
|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities |
Not linked to the securities |
|||
| FMR LLC | 0 | 0 | |||||
| Fidelity Management & Research Company LLC |
408,246 | 397,873 | 0.98% | ||||
| FIAM LLC | 5,979 | 11,777 | 0.03% | ||||
| FMR Investment Management (UK) Limited |
0 | 170,000 | 0.42% | ||||
| Subtotal | 414,225 | 579,650 | 1.43% | ||||
| TOTAL | 579,650 | 0 | 1.43% | 0.00% |
| B) Equivalent financial instruments | After the transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | ||
| TOTAL | 0 | 0.00% | ||||||
| The totals will be updated once you have clicked on |
||||||||
| TOTAL (A & B) | # of voting rights | % of voting rights | ||||||
| CALCULATE | 579,650 | 1.43% |
• Full chain of controlled undertakings through which the holding is effectively held
FIAM LLC is controlled by FIAM Holdings LLC; FMR Investment Management (UK) Limited is controlled by Fidelity Management & Research Company LLC; FIAM Holdings LLC, Fidelity Management & Research Company LLC are controlled by FMR LLC; FMR LLC is not a controlled undertaking.
• Additional information
The holdings attributed to the entities mentioned in the table arise from holdings of various undertakings for collective investment that are managed by FIAM LLC, FMR Investment Management (UK) Limited, and Fidelity Management & Research Company LLC each of which are entities that are subsidiaries of and controlled by FMR LLC. The entities mentioned in the table are the discretionary investment managers and exercise the voting rights at their discretion in the absence of specific instructions.
1% threshold, as stipulated in the Articles of Association, crossed downards by Fidelity Management & Research Company LLC, a controlled undertaking of FMR LLC.
Press release | 28/04/2025
2
• About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2.000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
For further information, please contact:
Elena De Landy Paralegal: Corporate Affairs and Insurance [email protected]
Press release | 28/04/2025
